AIFF: Total Utang marang Modal Firefly Neuroscience

Logo perusahaan publik Firefly Neuroscience (AIFF)

The price visualization on GURU.Markets for Firefly Neuroscience, Inc (AIFF), which assists in the basic asset valuation, shows a debt-to-equity ratio of 0.00. Firefly Neuroscience, Inc is developing an AI environment for brain function analysis, expanding its network of clinics in the US thanks to FDA certification. The business monetizes cloud services for psychiatrists, creating high software dependency among specialists, while minimizing risks through the accurate detection of dementia.

AIFF - Total Utang marang Modal Firefly Neuroscience ing rentang 04.07.2022 - 30.10.2026

Rincian metrik lan analitis perusahaan Firefly Neuro (AIFF)

- rega lan prakiraan konsensus rega:
Bagan rega Firefly Neuroscience|AIFF - Prakiraan gabungan firma investasi
- informasi kapitalisasi pasar:
Kapitalisasi pasar Firefly Neuroscience|AIFF - Total Nilai Perusahaan
- indikator kapitalisasi buku:
Nilai Akuntansi saben Saham Firefly Neuroscience|AIFF - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku fireflyneuro.com|AIFF - Nilai Agregat Aset
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Firefly Neuroscience, Inc|AIFF - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Firefly Neuroscience, Inc|AIFF - Gunggung tanggungan utang perusahaan|Utang-utang marang kapitalisasi buku Firefly Neuroscience|AIFF - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Firefly Neuroscience|Rasio cepet fireflyneuro.com
- statistik bathi lan rasio pasar:
AIFF - Penghasilan resik perusahaan
Ringkesan analitik perusahaan:Firefly Neuroscience, AIFF
Barang utama Firefly Neuro

Firefly Neuroscience, Inc (AIFF) is developing patent-protected AI algorithms for EEG analysis, which requires significant investment in FDA certification. The trend in total debt-to-equity ratio demonstrates the company's level of reliance on borrowed funds, measuring financial stability risk through the proportion of liabilities to equity, which allows investors to assess the business's margin of safety while scaling medical technologies.

Analisis pesaing

Utang marang Ekuitas Biogen|Rasio Utang marang Ekuitas NBIX (Neurocrine)|Total Utang marang Modal RGC|AXSM - Utang marang Modal|ACADIA Pharmaceuticals - Rasio Total Utang marang Ekuitas|Total Utang marang Modal xenon-pharma.com XENE|VKTX - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SUPN (Supernus Pharmaceuticals, Inc.)|Catalyst Pharmaceuticals Inc (CPRX) - Utang marang Ekuitas|Utang marang Modal Denali Corp (DNLI)|HRMY (Harmony Biosciences) - Total Utang marang Modal|biohavenpharma.com - Utang Agregat marang Ekuitas|Total Utang marang Modal AMLX|Koefisien Total Utang marang Modal Trevi Therapeutics Inc|Utang marang Ekuitas Praxis Medicines PRAX|Rasio Kabeh Utang marang Dana Pribadi AVXL|CeriBell, Inc. - Total Utang marang Modal|Utang marang Modal Prothena Corporation PLC|ALEC: Total Utang marang Modal|Utang Agregat marang Ekuitas ANNX (Annexon Biosciences)|Utang marang Ekuitas Omeros Corp|Utang marang Ekuitas NGNE|Rasio Total Utang marang Ekuitas ACIU (AC Immune)|VYGR - Utang marang Modal|Neumora Therapeutics, Inc. - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SCLX|TVGN - Utang marang Ekuitas|ACOG (Alpha Cognition) - Rasio Utang marang Ekuitas|CGTX: Total Utang marang Modal|Utang marang Modal inhibikase.com (IKT)|Rasio Total Utang marang Ekuitas SAVA|Total Utang marang Modal Assertio Therapeutics|Utang marang Ekuitas Coya Therapeutics, Inc. (COYA)|VTGN (vistagen.com) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Ovid Therapeutics OVID|acumenpharm.com (ABOS) - Utang marang Modal|CRVO - Utang marang Ekuitas|Koefisien Total Utang marang Modal Alterity Therapeutics ATHE|CLNN: Total Utang marang Modal|Rasio Total Utang marang Ekuitas PepGen|JUNS (Jupiter Neurosciences Inc) - Total Utang marang Modal|relmada.com (RLMD) - Koefisien Total Utang marang Modal|Total Utang marang Modal ANVS|GRCE - Utang marang Modal|Utang marang Ekuitas Klotho Neurosciences KLTO|NRSN: Rasio Utang marang Ekuitas|Reviva Pharmaceuticals - Total Utang marang Modal|MetaVia Inc (MTVA) - Rasio Total Utang marang Ekuitas|NRXS: Total Utang marang Modal|Utang marang Modal Helius Medical Technologies (HSDT)|Rasio Total Utang marang Ekuitas PASG|NEUP: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal NERV|Koefisien Total Utang marang Modal athira.com|Utang marang Ekuitas Addex Therapeutics Ltd ADXN|ALZN: Rasio Utang marang Ekuitas|Cyclerion - Total Utang marang Modal|Protagenic Therapeutics (PTIX) - Rasio Total Utang marang Ekuitas|KTTA: Total Utang marang Modal|Cortigent (CRGT) - Total Utang marang Modal|ATXI (Avenue Therapeutics, Inc.) - Total Utang marang Modal|Brainstorm Cell Therapeutics Inc. (BCLI) - Koefisien Total Utang marang Modal|Total Utang marang Modal CARA|CHRO: Utang Agregat marang Ekuitas|Total Utang marang Modal ELYM (Eliem Therapeutics Inc.)|ITCI (Intra-Cellular Therapies Inc.) - Utang Agregat marang Ekuitas|LBPH - Utang marang Ekuitas|MRNS (Marinus Pharmaceuticals Inc) - Rasio Utang marang Ekuitas|NKGN: Total Utang marang Modal|Utang marang Modal NeuroBo Pharma (NRBO)|Rasio Total Utang marang Ekuitas SAGE|Total Utang marang Modal synaptogen.com|Utang marang Ekuitas Trevena (TRVN)|VIGL (vigilneuro.com) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Anew Medical WENA|Cerevel Corp (CERE) - Utang marang Modal